In vivo assessment of smt 19969 in a hamster model of clostridium difficile infection

Keyphrases

• Clostridium Difficile Infection 100%
• Hamster Model 100%
• In Vivo Assessment 100%
• SMT19969 100%
• Vancomycin 66%
• Epidemic Strain 33%
• Plasma Samples 16%
• Once-daily 16%
• Dose Rate 16%
• In Vitro Activity 16%
• 4-fold 16%
• Limit of Quantification 16%
• Difficile 16%
• Survival Rate 16%
• Pyridyl 16%
• Narrow Spectrum 16%
• Non-absorbable Antibiotic 16%
• Full Protection 16%
• % Protection 16%
• Sample Concentration 16%
• Bibenzimidazole 16%

Immunology and Microbiology

• Minimum Inhibitory Concentration 100%
• Peptoclostridium difficile 100%
• Hamster Model 100%
• Body Weight 33%
• Blood Plasma 33%
• Survival Rate 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Vancomycin 100%
• Clostridium Difficile Infection 100%
• Hamster Model 100%
• Bioavailability 25%
• Survival Rate 25%